Good evening :)

How to use scorecard? Learn more

AMC Logo

Tata India Pharma & Healthcare Fund Standard Growth

GrowthRegular
33.830.04% (-0.01)
High
Low
Returns
0.00%
0.00%
1M
6M
1Y
3Y
5Y
Max
SIP
Loading...
1M
6M
1Y
3Y
5Y
Max
SIP

Mid-size Fund

Assets Under Mgmt: ₹ 1,455 Cr

Very High Risk

Principle investment will be at very high risk

Scorecard

Performance

Avg

Return has been average, nothing exciting vs others

Risk

Low

Stay at ease, amongst the lower risk funds

Cost

Low

Expense that wouldn't create any worry

Composition

Avg

Average allocation strategy, nothing exciting

Red flags

Low

We got you covered, no major red flags identified

How to use scorecard? Learn more

Mid-size Fund

Assets Under Mgmt: ₹ 1,455 Cr

Very High Risk

Principle investment will be at very high risk

Tata India Pharma & Healthcare Fund Performance & Key Metrics

Tata India Pharma & Healthcare Fund Performance & Key Metrics

Expense RatioExpense RatioNo LabelNo LabelNo LabelNo Label
2.2844.640.75
No LabelNo LabelNo LabelNo LabelNo LabelNo Label
1.7346.681.15

Tata India Pharma & Healthcare Fund Scheme InfoTata India Pharma & Healthcare Fund Scheme Info

PlanPlanLock inLock inExit LoadExit Load
Growth0 yrs0.25%
0.25% on or before 30D
SIP Inv.SIP Inv.Min. LumpsumMin. Lumpsum
Allowed₹ 5,000
Initial: ₹ 5,000 Incremental: ₹ 1,000
BenchmarkBenchmark
BSE Health Care - TRI

About Sectoral Fund - Pharma & Health Care

About Sectoral Fund - Pharma & Health Care

Sectoral Funds - Pharma & Health Care are equity schemes that majorly invest in healthcare sector companies. It will give exposure to entire healthcare sector which comprised a wide range of companies involved in medical services, medical equipments, drugs and medical insurance.

Tata India Pharma & Healthcare Fund Portfolio

Tata India Pharma & Healthcare Fund Asset Allocation

Tata India Pharma & Healthcare Fund Asset Allocation

Actual

Target

Dec 2025

Mar 2026

Jun 2026

Jul 2026

ACTUAL
Cash & EquivalentsEquity0.86%99.14%

Dec 2025

Mar 2026

Jun 2026

Jul 2026

Tickertape Separator

Tata India Pharma & Healthcare Fund Sector Distribution

Tata India Pharma & Healthcare Fund Sector Distribution

+2 moreFMCG - Household ProductsOthersFertilizers & Agro ChemicalsLabs & Life Sciences ServicesPharmaceuticals1.22 %1.15 %3.56 %4.85 %28.92 %60.30 %

Dec 2025

Mar 2026

Jun 2026

Jul 2026

Tickertape Separator

Tata India Pharma & Healthcare Fund Sector Weightage

Tata India Pharma & Healthcare Fund Sector Weightage

Jun 25Sep 25Dec 25Mar 26Jun 26Jul 2657.70%56.86%58.28%58.69%59.73%60.30%
Pharmaceuticals as a % of total holdings for last six quarters
Tickertape Separator

Tata India Pharma & Healthcare Fund Current Holdings

Tata India Pharma & Healthcare Fund Current Holdings

Equity

Others

  • Constituent
    Holding Weight
    3M Change

AMC Profile of Tata India Pharma & Healthcare Fund

AMC Profile of Tata India Pharma & Healthcare Fund

Established in 1994, Tata Asset Management Private Limited has a track record of more than 25 years in investment management. Tata Asset Management Private Limited manages investments of Tata Mutual Fund.

Established in 1994, Tata Asset Management Private Limited has a track record of more than 25 years in investment management. Tata Asset Management Private Limited manages investments of Tata Mutual Fund.

  • No.of Schemes

    62

  • Total AUM

    ₹ 2,21,546.68 Cr.

Tata India Pharma & Healthcare Fund Manager Details

Tata India Pharma & Healthcare Fund Manager Details

Tata India Pharma & Healthcare Fund Manager Profile

Tata India Pharma & Healthcare Fund Manager Profile

Rajat Srivastava

AUM:  ₹1,455.16 Cr.

Sum of AUMs of all funds managed by the fund manager

 | 

Exp: 8yrs

Qualification

BBA (Banking & Insurance), PGDM - IMT Ghaziabad

Past Experience

With over eight years of industry experience across buy-side and sell-side firms, Mr. Rajat Srivastava brings strong equity research expertise to Tata Asset Management. As an Assistant Fund Manager and Research Analyst, he focuses on the Healthcare and Chemicals sectors, contributing to informed investment decisions and strategic insights in these areas. Before joining Tata Asset Management, Mr. Srivastava held positions at Incred Asset Management, Kotak Investment Banking, and Motilal Oswal Institutional Equities, where he further honed his analytical and financial acumen. Mr. Srivastava holds a Post Graduate Diploma in Management (PGDM) from IMT Ghaziabad.

Funds Managed (2)
13.57%
13.57%
20.11%
20.11%
0.97%
0.97%
11.95%
11.95%
18.36%
18.36%
2.28%
2.28%

Tata India Pharma & Healthcare Fund Manager Performance (0)

Tata India Pharma & Healthcare Fund Manager Performance (0)

Loading...

Frequently asked questions

Frequently asked questions

  1. What is the current price / NAV of Tata India Pharma & Healthcare Fund?

    The current NAV of Tata India Pharma & Healthcare Fund is ₹33.83, as of 7th August 2026.

  2. What are the returns of Tata India Pharma & Healthcare Fund?

    The Tata India Pharma & Healthcare Fund was launched on 28th December 2015. This mutual fund's past returns are as follows:
    • 1 Year Returns: 11.95%
    • 3 Year Returns: 18.36%
    • 5 Year Returns: 13.65%

  3. What are the top 5 sectoral holdings of Tata India Pharma & Healthcare Fund?

    The top sectors Tata India Pharma & Healthcare Fund has invested in are as follows:
    • Pharmaceuticals | 60.30%
    • Labs & Life Sciences Services | 28.92%
    • Fertilizers & Agro Chemicals | 4.85%
    • Others | 3.56%
    • FMCG - Household Products | 1.15%
    This data is as on 7th August 2026.

  4. What are the top 5 holdings of Tata India Pharma & Healthcare Fund?

    The top 5 holdings for Tata India Pharma & Healthcare Fund are as follows:
    • Sun Pharmaceutical Industries Ltd | 8.59%
    • Divi's Laboratories Ltd | 6.36%
    • Healthcare Global Enterprises Limited | 5.85%
    • Abbott India Ltd | 5.63%
    • Rainbow Children's Medicare Ltd | 4.90%
    This data is as on 7th August 2026.

  5. What is the asset allocation of Tata India Pharma & Healthcare Fund?

    The asset allocation for Tata India Pharma & Healthcare Fund is as follows:
    • Equity | 99.14%
    • Cash & Equivalents | 0.86%
    This data is as on 7th August 2026.

  6. What is the AUM of Tata India Pharma & Healthcare Fund?

    The AUM (i.e. assets under management) of Tata India Pharma & Healthcare Fund is ₹1455.16 Cr as of 7th August 2026.

  7. What is the expense ratio of Tata India Pharma & Healthcare Fund?

    The expense ratio of Tata India Pharma & Healthcare Fund Plan is 2.28 as of 7th August 2026.

  8. What is the alpha ratio of Tata India Pharma & Healthcare Fund?

    The alpha ratio for the Tata India Pharma & Healthcare Fund is 4.20

    Alpha is the excess return of a fund compared to its expected return, based on its beta and the risk-free rate. Positive alpha indicates that the fund has outperformed its expected return, while negative alpha suggests underperformance.

  9. What is the volatility or standard deviation of Tata India Pharma & Healthcare Fund?

    The volatility or standard deviation for the Tata India Pharma & Healthcare Fund is 11.71

    Standard deviation measures the volatility or risk associated with the returns of a mutual fund. A higher standard deviation indicates higher volatility, suggesting that the returns of the mutual fund are more spread out from the average. On the other hand, a lower standard deviation implies lower volatility and a more stable performance.

  10. What is the sharpe ratio of Tata India Pharma & Healthcare Fund?

    The Sharpe ratio for the Tata India Pharma & Healthcare Fund is 0.75

    The Sharpe ratio is a measure of risk-adjusted return that evaluates the performance of a mutual fund, by adjusting for its risk. Higher Sharpe ratio indicates a better risk-adjusted performance. A positive Sharpe ratio indicates that the MF has provided a return in excess of the risk-free rate for the amount of risk taken. Conversely, a negative Sharpe ratio suggests that the MF did not adequately compensate for the risk.

  11. What is the Sortino ratio of Tata India Pharma & Healthcare Fund?

    The Sortino Ratio for the Tata India Pharma & Healthcare Fund is 0.08

    The Sortino ratio of a mutual fund is a measure of its risk-adjusted return, considering only downside volatility. It helps investors evaluate how well a fund is performing relative to its downside risk. A higher Sortino ratio (value >1) means the fund generates better returns for the downside risk taken.

  12. What is the Price to Earnings (PE) ratio of Tata India Pharma & Healthcare Fund?

    The PE ratio of Tata India Pharma & Healthcare Fund is 44.64, while category PE ratio is 46.68.